ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36165
-0.01%
Bitcoin
66,977.76
-0.15%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Synaptogenix Inc (SNPX)

  7. Synaptogenix Inc (SNPX) News

SNPX

Synaptogenix (SNPX)

Synaptogenix Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNPX
DateTimeSourceHeadlineSymbolCompany
05/15/20244:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNPXSynaptogenix Inc
05/07/20248:00AMPR Newswire (US)Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug DiscoveryNASDAQ:SNPXSynaptogenix Inc
04/24/20248:15AMPR Newswire (US)Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued ListingNASDAQ:SNPXSynaptogenix Inc
04/09/20248:15AMPR Newswire (US)Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Company through its Partnership with Cannasoul AnalyticsNASDAQ:SNPXSynaptogenix Inc
04/03/20247:00AMPR Newswire (US)Synaptogenix Announces Reverse Stock Split to Maintain Nasdaq ListingNASDAQ:SNPXSynaptogenix Inc
02/06/20249:16AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SNPXSynaptogenix Inc
12/21/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNPXSynaptogenix Inc
12/19/20238:00AMPR Newswire (US)Synaptogenix President Daniel L. Alkon, M.D. Honored for Scientific Presentation at USC-Sponsored Forum on Age-Related Diseases and Neurodegenerative DisordersNASDAQ:SNPXSynaptogenix Inc
12/06/20238:00AMPR Newswire (US)Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases including Alzheimer'sNASDAQ:SNPXSynaptogenix Inc
11/14/20234:05PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:SNPXSynaptogenix Inc
11/13/20234:00PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SNPXSynaptogenix Inc
11/06/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNPXSynaptogenix Inc
11/03/20234:00PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SNPXSynaptogenix Inc
11/02/20238:00AMPR Newswire (US)Synaptogenix Acquires Significant Stake in Cannasoul Analtyics Ltd. Co-founded by The Technion - Israel Institute of TechnologyNASDAQ:SNPXSynaptogenix Inc
09/26/20238:00AMPR Newswire (US)Synaptogenix Announces Peer-Reviewed Publication of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, and Persistent Benefits of Bryostatin-1 in Advanced Alzheimer's DiseaseNASDAQ:SNPXSynaptogenix Inc
09/22/20233:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNPXSynaptogenix Inc
09/07/20238:00AMPR Newswire (US)Bryostatin-1 from Synaptogenix Shows Statistically Significant Results as an ALS Treatment in Pre-Clinical Independent StudyNASDAQ:SNPXSynaptogenix Inc
08/14/20234:00PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNPXSynaptogenix Inc
07/19/20238:00AMPR Newswire (US)Synaptogenix and Cleveland Clinic to Submit Investigational New Drug (IND) Application to FDA for Clinical Trial of Bryostatin-1 in Multiple SclerosisNASDAQ:SNPXSynaptogenix Inc
07/19/20237:55AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNPXSynaptogenix Inc
07/13/20238:00AMPR Newswire (US)Synaptogenix Abstract Highlighting Bryostatin-1 Benefits in Severe Alzheimer's Disease Accepted for Presentation at 11th International Brain Research Organization World Congress of NeuroscienceNASDAQ:SNPXSynaptogenix Inc
06/22/20234:15PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNPXSynaptogenix Inc
05/15/20233:51PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SNPXSynaptogenix Inc
04/28/20234:08PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNPXSynaptogenix Inc
04/14/20234:01PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SNPXSynaptogenix Inc
03/31/20233:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNPXSynaptogenix Inc
03/31/20233:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNPXSynaptogenix Inc
03/31/20233:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNPXSynaptogenix Inc
03/31/20233:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNPXSynaptogenix Inc
03/21/20234:24PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:SNPXSynaptogenix Inc
 Showing the most relevant articles for your search:NASDAQ:SNPX

Your Recent History

BIT
UB0TDH
UniCredit Bank
COIN
CGGETH
ChainGuardians Governance Token
COIN
PTPUST
Platypus
ASX
WKT
Walkabout Resources
HUOB
DOTBTC
Polkadot
USOTC
MPVDF
Mountain Province Diamonds (PK)
LSE
SOUC
Southern Energy
LSE
103A
BITMOT
889223
Intsanpaolo Green Bond T...
COIN
BREEDUSD
BreederDAO
COIN
XECBTC
eCash
LSE
1GOO
1x Goog
AMEX
JKA
COIN
PRNTETH
PrimeNumbers
DGFX
RVCUSDT
Revenue Coin
BIT
SXLI
Spdr S&p U.s. Industrial...
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved